Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-27

Clinical Trial Update: Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

This Phase 3 trial entry describes a planned study to evaluate the efficacy and safety of semaglutide for weight loss in overweight or obese adults in Banglades…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • semaglutide (semaglutide)

Snippet

Sponsor: Popular Medical College Hospital | Conditions: Obesity, Type 2 Diabetes Mellitus (T2DM) | Phase 3 | Status: NOT_YET_RECRUITING